Literature DB >> 21921622

Delayed kidney allograft function - what does it tell us about acute kidney injury?

Bassam G Abu Jawdeh, Hamid Rabb.   

Abstract

Ischemia-reperfusion (IR) injury plays a significant role in the pathogenesis of both delayed graft function (DGF) in allografts and hemodynamic mediated acute kidney injury (AKI) of native kidneys. IR injury involves the interplay of several factors, including both the innate and adaptive immune systems. Though the final effector mechanisms causing injury are likely similar in both allograft and native kidneys, DGF is confounded by various donor, recipient and graft-handling factors. DGF is becoming increasingly important because of the growing number of patients awaiting kidney transplant. Identifying mediators, new diagnostics and therapeutics for DGF is important to provide more kidneys for transplant and improve outcomes. Furthermore, given that DGF occurs in a tightly controlled scenario, studying DGF is useful for early studies of proof of principle for biomarkers and therapeutics prior to launching into less wellcontrolled studies in large numbers of native kidney AKI patients.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21921622     DOI: 10.1159/000329395

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  4 in total

1.  Proton Nuclear Magnetic Resonance (¹H-NMR)-Based Metabolomic Evaluation of Human Renal Allografts from Donations After Circulatory Death.

Authors:  Zijie Wang; Haiwei Yang; Chunchun Zhao; Jifu Wei; Junsong Wang; Zhijian Han; Jun Tao; Zhen Xu; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Med Sci Monit       Date:  2017-11-17

2.  C3a and C5a promote renal ischemia-reperfusion injury.

Authors:  Qi Peng; Ke Li; Lesley A Smyth; Guolan Xing; Naiyin Wang; Lucy Meader; Bao Lu; Steven H Sacks; Wuding Zhou
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

3.  Scavenging reactive oxygen species using tempol in the acute phase of renal ischemia/reperfusion and its effects on kidney oxygenation and nitric oxide levels.

Authors:  Ugur Aksu; Bulent Ergin; Rick Bezemer; Asli Kandil; Dan M J Milstein; Cihan Demirci-Tansel; Can Ince
Journal:  Intensive Care Med Exp       Date:  2015-07-04

4.  Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation.

Authors:  Matthew P Welberry Smith; Alexandre Zougman; David A Cairns; Michelle Wilson; Tobias Wind; Steven L Wood; Douglas Thompson; Michael P Messenger; Andrew Mooney; Peter J Selby; Andrew J P Lewington; Rosamonde E Banks
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.